Literature DB >> 11134518

Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice.

Y Geng1, Q Yu, E Sicinska, M Das, R T Bronson, P Sicinski.   

Abstract

D-type cyclins (cyclins D1, D2, and D3) are key components of cell cycle machinery in mammalian cells. These proteins are believed to drive cell cycle progression by associating with their kinase partners, cyclin-dependent kinases, and by directing phosphorylation of critical cellular substrates. In addition, D-cyclins play a kinase-independent role by sequestering cell cycle inhibitors p27(Kip1) and p21(Cip1). In the past, we and others generated cyclin D1-deficient mice and have shown that these mice display developmental abnormalities, hypoplastic retinas, and pregnancy-insensitive mammary glands. To test the significance of cyclin D1-p27(Kip1) interaction within a living mouse, we crossed cyclin D1-deficient mice with mice lacking p27(Kip1), and we generated double-mutant cyclin D1(-/-)p27(-/-) animals. Here we report that ablation of p27(Kip1) restores essentially normal development in cyclin D1-deficient mice. Our results provide genetic evidence that p27(Kip1) functions downstream of cyclin D1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134518      PMCID: PMC14567          DOI: 10.1073/pnas.98.1.194

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation.

Authors:  X Leng; L Connell-Crowley; D Goodrich; J W Harper
Journal:  Curr Biol       Date:  1997-09-01       Impact factor: 10.834

2.  New functional activities for the p21 family of CDK inhibitors.

Authors:  J LaBaer; M D Garrett; L F Stevenson; J M Slingerland; C Sandhu; H S Chou; A Fattaey; E Harlow
Journal:  Genes Dev       Date:  1997-04-01       Impact factor: 11.361

3.  Cyclin E-induced S phase without activation of the pRb/E2F pathway.

Authors:  J Lukas; T Herzinger; K Hansen; M C Moroni; D Resnitzky; K Helin; S I Reed; J Bartek
Journal:  Genes Dev       Date:  1997-06-01       Impact factor: 11.361

Review 4.  D-type cyclins.

Authors:  C J Sherr
Journal:  Trends Biochem Sci       Date:  1995-05       Impact factor: 13.807

Review 5.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

6.  A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.

Authors:  M L Fero; M Rivkin; M Tasch; P Porter; C E Carow; E Firpo; K Polyak; L H Tsai; V Broudy; R M Perlmutter; K Kaushansky; J M Roberts
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

Review 7.  Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer.

Authors:  C Dickson; V Fantl; C Gillett; S Brookes; J Bartek; R Smith; C Fisher; D Barnes; G Peters
Journal:  Cancer Lett       Date:  1995-03-23       Impact factor: 8.679

8.  A novel cyclin encoded by a bcl1-linked candidate oncogene.

Authors:  T Motokura; T Bloom; H G Kim; H Jüppner; J V Ruderman; H M Kronenberg; A Arnold
Journal:  Nature       Date:  1991-04-11       Impact factor: 49.962

9.  p21-containing cyclin kinases exist in both active and inactive states.

Authors:  H Zhang; G J Hannon; D Beach
Journal:  Genes Dev       Date:  1994-08-01       Impact factor: 11.361

10.  Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis.

Authors:  J Bartkova; J Lukas; M Strauss; J Bartek
Journal:  Oncogene       Date:  1995-02-16       Impact factor: 9.867

View more
  49 in total

1.  Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer.

Authors:  Yoku Hayakawa; Yoshihiro Hirata; Hayato Nakagawa; Kei Sakamoto; Yohko Hikiba; Hiroto Kinoshita; Wachiko Nakata; Ryota Takahashi; Keisuke Tateishi; Motohisa Tada; Masao Akanuma; Haruhiko Yoshida; Kohsuke Takeda; Hidenori Ichijo; Masao Omata; Shin Maeda; Kazuhiko Koike
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Lhx4 deficiency: increased cyclin-dependent kinase inhibitor expression and pituitary hypoplasia.

Authors:  Peter Gergics; Michelle L Brinkmeier; Sally A Camper
Journal:  Mol Endocrinol       Date:  2015-02-10

Review 3.  New roles of cyclin D1.

Authors:  Richard G Pestell
Journal:  Am J Pathol       Date:  2013-07       Impact factor: 4.307

4.  Zic2 controls cerebellar development in cooperation with Zic1.

Authors:  Jun Aruga; Takashi Inoue; Jun Hoshino; Katsuhiko Mikoshiba
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

Review 5.  Meet me in the cytoplasm: A role for p27(Kip1) in the control of H-Ras.

Authors:  Gustavo Baldassarre; Barbara Belletti
Journal:  Small GTPases       Date:  2016-04-08

Review 6.  Cyclin D as a therapeutic target in cancer.

Authors:  Elizabeth A Musgrove; C Elizabeth Caldon; Jane Barraclough; Andrew Stone; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

Review 7.  Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice.

Authors:  Elizabeth A Musgrove; Elizabeth A Davison; Christopher J Ormandy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

Review 8.  Cyclins and breast cancer.

Authors:  Robert L Sutherland; Elizabeth A Musgrove
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

9.  Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma.

Authors:  Olivier Ayrault; Frederique Zindy; Jerold Rehg; Charles J Sherr; Martine F Roussel
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

10.  Aberrant cell cycle progression and endoreplication in regenerating livers of mice that lack a single E-type cyclin.

Authors:  Yulia A Nevzorova; Darjus Tschaharganeh; Nikolaus Gassler; Yan Geng; Ralf Weiskirchen; Piotr Sicinski; Christian Trautwein; Christian Liedtke
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.